Microdroplet type digital PCR (Polymerase Chain Reaction) detection method for drug-resistant genes in milk

By using a droplet-based digital PCR detection method, the sensitivity and quantification issues of drug resistance gene detection in milk have been resolved. This method enables absolute quantitative analysis of drug resistance genes with low detection limits, ensuring the specificity and repeatability of the detection.

CN118957036APending Publication Date: 2024-11-15JILIN VETERINARY SCI INST
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411240507.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-05
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

Existing methods for detecting drug resistance genes in milk are not sensitive enough to achieve absolute quantification, and qPCR detection methods have limited detection limits.

Method used

The droplet digital PCR detection method was adopted. By preparing the ddPCR reaction mixture, droplets were generated for PCR amplification and fluorescence signal reading. QuantaSoft software was used for quantitative analysis to achieve absolute quantitative detection of drug resistance genes.

Benefits of technology

It achieves absolute quantitative analysis of drug resistance genes in milk, with a detection limit as low as 0.06 copies/μL, and has good specificity and repeatability, enabling accurate detection of the presence of drug resistance genes in commercially available raw milk.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118957036A_ABST
    Figure CN118957036A_ABST
Patent Text Reader

Abstract

The invention relates to a droplet type digital PCR (Polymerase Chain Reaction) detection method for drug-resistant genes in milk, which belongs to the field of drug-resistant gene detection and comprises the following steps: preparing ddPCR reaction mixed liquor: ddPCR Supermix, an upstream primer, a downstream primer, a probe, a DNA (Deoxyribose Nucleic Acid) template and ddH2O; generating micro-droplets; carrying out PCR (Polymerase Chain Reaction) amplification; a fluorescence signal is read; and a result is quantitatively analyzed by QuantaSoft software. By establishing the ddPCR detection method for the drug-resistant genes in the milk, absolute quantitative analysis of the drug-resistant genes in the milk can be completed, the lower detection limit can be detected, the existence of the drug-resistant genes as low as 0.06 copies / mu L can be detected through ddPCR, and the lowest detection limit of the drug-resistant genes is defined. No cross reaction exists between the kit and other drug-resistant gene detection, the specificity is good, the range of the variable coefficient between the groups is 0.26%-0.81%, and the repeatability is good.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of drug-resistant gene detection, and specifically relates to a droplet digital PCR detection method for drug-resistant genes in milk. Background Art

[0002] At present, the main application forms of digital PCR include chip digital PCR and droplet digital PCR. Both forms can effectively distribute nucleic acid samples to a large number of independent and parallel micro-reaction units, ensuring that each reaction unit contains only one template molecule as much as possible, and on this basis, amplification, detection and distribution statistics are performed to achieve absolute counting of target molecules. In terms of application fields, the wide application of digital PCR is reflected in many aspects, including gene instability analysis, prenatal diagnosis, microbial detection, transgenic detection and DNA sequencing. There are also many applications in the field of food safety testing, including the following aspects: foodborne pathogen detection research, animal and plant-derived component detection research, transgenic component detection research and foodborne virus detection research.

[0003] As a form of dPCR, the operation process of droplet digital PCR (ddPCR) technology mainly includes three parts: droplet generation, amplification, and fluorescence signal analysis. In the droplet generation stage, the droplet generator plays a key role, which can convert the fluorescent quantitative PCR reaction system containing nucleic acid molecules into tiny droplets. Each droplet is equivalent to an independent PCR reactor, which means that the PCR reaction can be carried out independently in these tiny, isolated environments. In the PCR amplification stage, the sample is divided into thousands of droplets. Each droplet contains nucleic acid molecules, and these droplets act as independent reactors in the PCR reaction. This method allows the nucleic acid molecules in each droplet to be accurately amplified and detected. After the PCR amplification is completed, the two-color optical detection system analyzes each droplet separately. In this process, the system measures the fluorescence signal in each droplet. If the droplet contains amplified nucleic acid molecules, it will emit a fluorescent signal, and such a droplet will be recorded as 1. On the contrary, if there are no nucleic acid molecules in the droplet or the number of nucleic acid molecules is lower than the detection threshold, it will not emit a fluorescent signal, and such a droplet will be recorded as 0. The reaction unit with a fluorescent signal contains at least one copy of the target molecule. During the PCR reaction, fluorescent dyes or probes emit fluorescent signals, which can be detected and recorded by the instrument. By analyzing these fluorescent signals, it can be determined whether each droplet contains nucleic acid target molecules and the number of target molecules. Since each droplet is independent, the absolute number of nucleic acid target molecules can be directly calculated without relying on a standard curve. The quantitative method of droplet digital PCR (ddPCR) does not rely on the cycle threshold of the amplification curve, which is a significant advantage over traditional PCR technology. Since ddPCR determines the number of target molecules by directly counting droplets with fluorescent signals, its quantitative results are not affected by the efficiency of PCR amplification. In addition, ddPCR does not require the use of housekeeping genes and standard curves for quantification, which makes its operation simpler and avoids quantitative errors caused by improper selection of housekeeping genes or incorrect standard curve settings. The high accuracy and reproducibility of ddPCR also benefit from its unique quantitative principle. By performing independent PCR amplification and fluorescent signal detection on a large number of droplets, ddPCR can accurately calculate the number of target molecules, thereby achieving absolute quantitative analysis.

[0004] With the continued use of antibiotics, the accumulation of antibiotic resistance in the environment has become an inevitable problem that the world must face, so the research and development of technology for detecting drug-resistant genes is urgent.

[0005] At present, the existing method for detecting drug-resistant genes in milk is the fluorescent quantitative PCR detection method, which has the following disadvantages:

[0006] (1) The sensitivity of conventional PCR and qPCR detection methods is not high;

[0007] (2) The qPCR detection method cannot achieve absolute quantification;

[0008] (3) The qPCR detection method can detect limited concentrations. Summary of the invention

[0009] The purpose of the present invention is to provide a droplet digital PCR detection method for drug-resistant genes in milk. The method of the present invention can complete the absolute quantitative analysis of drug-resistant genes in milk and detect a lower detection limit.

[0010] The technical solution adopted by the present invention to solve the technical problem is as follows:

[0011] The present invention provides a droplet digital PCR detection method for drug resistance genes in milk, which specifically comprises the following steps:

[0012] (1) Prepare ddPCR reaction mixture, including: ddPCR Supermix, upstream primer, downstream primer, probe, DNA template and ddH2O;

[0013] The sequence information of the upstream primer, downstream primer and probe is shown in the following table:

[0014]

[0015]

[0016] (2) Droplet generation;

[0017] (3) PCR amplification;

[0018] The PCR reaction program was enzyme activation at 95°C for 8-10 min; denaturation at 94-98°C for 20-30 s for 35-45 cycles; annealing / extension at 50-60°C for 60-90 s for 35-45 cycles; enzyme inactivation at 98°C for 8-10 min; storage at 4°C;

[0019] (4) Fluorescence signal reading and quantitative analysis results using QuantaSoft software.

[0020] As a preferred embodiment, the total volume of the ddPCR reaction mixture is 22 μL, including 11 μL of ddPCR Supermix, 1.8 μL of upstream primer, 1.8 μL of downstream primer, 0.5 μL of probe, 2.2 μL of DNA template, and 4.7 μL of ddH2O.

[0021] As a preferred embodiment, the drug-resistant genes in the milk are AAC(6')-Ie, AAC(3)-IIa, ANT(6)-Ia, APH(6)-Id, APH(3")-Ib, tetA, tetB, tetD, tetO and tetS.

[0022] As a preferred embodiment, the minimum detection limits of the drug-resistant genes AAC(6')-Ie, AAC(3)-IIa, ANT(6)-Ia, APH(6)-Id, APH(3")-Ib, tetA, tetB, tetD, tetO and tetS are 0.06 copies / μL, 0.10 copies / μL, 0.24 copies / μL, 0.09 copies / μL, 0.23 copies / μL, 0.19 copies / μL, 0.15 copies / μL, 0.31 copies / μL, 0.12 copies / μL and 0.33 copies / μL, respectively.

[0023] As a preferred embodiment, the coefficient of variation of the drug resistance genes AAC(6')-Ie, AAC(3)-IIa, ANT(6)-Ia, APH(6)-Id, APH(3")-Ib, tetA, tetB, tetD, tetO and tetS is distributed in the range of 0.26%-0.81%.

[0024] The beneficial effects of the present invention are:

[0025] The present invention can complete the absolute quantitative analysis of drug-resistant genes in milk and detect a lower detection limit by establishing a ddPCR detection method for drug-resistant genes in milk, that is, when qPCR and ddPCR simultaneously detect drug-resistant genes in 60 portions of commercially available fresh milk, both can detect the presence of drug-resistant genes, and ddPCR can detect the presence of drug-resistant genes as low as 0.06 copies / μL, clarifying the minimum detection limit of drug-resistant genes. The method of the present invention has no cross-reaction with other drug-resistant gene detections, has good specificity, and the coefficient of variation between groups ranges from 0.26% to 0.81%, with good repeatability. BRIEF DESCRIPTION OF THE DRAWINGS

[0026] Figure 1 This is a diagram of the generation of aminoglycoside resistance gene ddPCR droplets. In the figure: 1: AAC(6')-Ie; 3: AAC(3)-IIa; 5: ANT(6)-Ia; 7: APH(6)-Id; 9: APH(3")-Ib; 2, 4, 6, 8, 10: nucleic acid templates containing other resistance genes.

[0027] Figure 2This is a diagram of tetracycline resistance gene ddPCR droplet generation. In the figure: 1: tetA; 3: tetB; 5: tetD; 7: tetO; 9: tetS; 2, 4, 6, 8, 10: nucleic acid templates containing other resistance genes.

[0028] Figure 3 It is the sensitivity detection limit of drug resistance gene AAC(6')-Ie. DETAILED DESCRIPTION

[0029] The following will be combined with the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making creative work are within the scope of protection of the present invention.

[0030] 1. Main reagents and instruments

[0031] The main reagents and sources involved in the experiment are shown in Table 1, and the main instruments and sources used in the experiment are shown in Table 2.

[0032] Table 1 Main reagents and sources

[0033]

[0034]

[0035] Table 2 Main instruments and sources

[0036] Name of instrument Manufacturer Vortex Mixer MS3 Thermo Fisher Scientific, USA Fluorescence PCR instrument BIO-RAD, USA Small desktop high-speed centrifuge FRESCO21 Thermo Fisher Scientific, USA Biological Safety Cabinet 1300-A2 LABCONCO USA QX200 droplet generator BIO-RAD, USA QX200 droplet reader BIO-RAD, USA PX1PCRplatesealer BIO-RAD, USA Multi-specification manual pipettes Mettler-Toledo (RAININ) 1 / 10,000 electronic balance TX223L Sartorius Instruments GmbH

[0037] 2. Establishment of droplet digital PCR (ddPCR) detection method

[0038] In this experiment, the QX200AutoDG droplet digital PCR system manufactured by Bio-Rad Corporation of the United States was used as the experimental instrument. The experimental operation process mainly includes four key links: first, the precise preparation of the ddPCR reaction mixture, which is the basis for ensuring the accuracy of the experiment; followed by the generation of droplets and the PCR amplification process, which is crucial for achieving efficient replication of the target DNA molecule; then, the reading of the fluorescent signal, through this step, the real-time information of the PCR reaction can be obtained; finally, the quantitative analysis results are processed using QuantaSoft software to obtain accurate experimental results. The specific operation steps are as follows:

[0039] 1) Preparation of ddPCR reaction mixture

[0040] Select 22μL as the volume of the reaction system. The ratio of the optimal reaction system is detailed in Table 3. After mixing the components, vortex thoroughly to mix and briefly centrifuge to remove any bubbles that may be generated. It is worth noting that the ddPCR detection method has a higher sensitivity than both ordinary PCR and qPCR, so it is more susceptible to contamination by genomic DNA of other bacteria during the test. To ensure the accuracy of the test results, the PCR reaction mixture must be prepared under strict sterile conditions.

[0041] Table 3 Reaction mixture system of ddPCR detection method

[0042] Reagents volume ddPCRSupermix 11μL 10μMF 1.8μL 10μMR 1.8μL 10μMP 0.5μL DNA 2.2μL <![CDATA[ddH2O]]> 4.7μL Total volume 22μL

[0043] According to the requirements and set values, the gene analysis software Geneious Prime provides 25 pairs of primer probe combinations. The given primer probe combinations are compared with the NCBI gene library BLAST, and then the primer probes are verified using the PrimerExpress software to avoid the hairpin structure and dimer formed by the primer probes themselves, and to determine the primer probes of aminoglycoside and tetracycline resistance genes that finally meet the conditions. The specific primer probe sequences are shown in Table 4.

[0044] Table 4 Primers and probes for droplet digital PCR

[0045]

[0046]

[0047] 2) Droplet generation and PCR amplification

[0048] First, place a new DG8 cartridge in the holder, then take 11 μL of each 22 μL reaction mixture twice and add it to the 8 wells in the second row of the DG8 cartridge. Next, add 70 μL of droplet generation oil DGOil to each of the 8 wells in the third row of the DG8 cartridge, and make sure that each well is evenly covered. After that, cover with a rubber pad to ensure sealing. After completing the above steps, carefully and steadily place the holder in the droplet generator to start the droplet generation process. Once the droplet generation is complete, the total 40 μL droplets generated are divided into two times, and 20 μL of droplets from the first row of the DG8 cartridge are carefully taken each time and placed in a clean 96-well plate. When taking the droplets, pay special attention to hitting them as far as possible into the bottom of the 96-well plate to ensure the stability of the droplets. After transferring the droplets, immediately place the 96-well plate in the PCR plate sealer and seal it with aluminum foil. To ensure the sealing quality, the temperature of the sealing machine was set to 180°C for preheating, and the sealing time was set to 5 seconds. The 96-well plate sealed with aluminum foil was placed in the PCR instrument, and the PCR program was set as shown in Table 5 for PCR amplification.

[0049] Table 5 PCR reaction program

[0050] step temperature time Number of cycles Enzyme activation 95℃ 8-10min 1 transsexual 94-98℃ 20-30s 35-45 Annealing / Extension 50-60℃ 60-90s 35-45 Enzyme inactivation 98℃ 8-10min 1 save 4℃ ∞ 1

[0051] 3) Fluorescence signal reading and quantitative analysis results using QuantaSoft software

[0052] After the PCR amplification in step 2) is completed, the 96-well plate is placed in the reader analyzer of the QX200 AutoDG droplet digital PCR system. Subsequently, the fluorescence signals of each drug-resistant gene are collected and read one by one under the FAM channel. Then, the read fluorescence signal data is quantitatively analyzed using the supporting QuantaSoft software. Through the precise calculation of the software, the copy number of each drug-resistant gene can be obtained.

[0053] 3. Specificity test of ddPCR detection method

[0054] Both ddPCR and qPCR are based on the amplification process of the target gene, followed by the detection of fluorescence intensity by the probe method, thereby achieving accurate quantification of the template amount. Therefore, primers and probes can be used for both. The effectiveness of primers and probes verified by qPCR and the optimized reaction conditions are also effective for ddPCR experiments. Therefore, ddPCR conducts evaluation tests of ddPCR detection methods based on the reaction conditions optimized by qPCR.

[0055] Under the optimized experimental conditions, genomic DNA containing AAC(6')-Ie, AAC(3)-IIa, ANT(6)-Ia, APH(6)-Id, APH(3")-Ib, tetA, tetB, tetD, tetO, and tetS resistance genes were used as positive templates, and genomic DNA not containing the resistance genes was selected from the high-throughput sequencing results as the test sample to verify the specificity of the ddPCR detection method.

[0056] The optimized ddPCR detection method was used to test the bacterial genomic DNA containing the target drug resistance gene and the bacterial genomic DNA containing other drug resistance genes. Three replicate wells were made for the same sample to fully evaluate the specificity of the ddPCR detection method. Figure 1 and Figure 2 As shown. The experimental results show that only the template detection wells containing the target drug-resistant gene have positive droplets, while other templates without the target drug-resistant gene have no positive droplet fluorescence signals detected, indicating that the ddPCR detection method can accurately identify and amplify the target drug-resistant gene, confirming that the ddPCR detection method has a high degree of specificity and will not cross-react with other drug-resistant genes. The droplet volume generated in each well is more than 11,000, which meets the standard requirements for droplet preparation. This proves that the optimized ddPCR detection method in this experiment has a high specificity, can accurately identify and amplify the target drug-resistant gene, and avoids cross-reactions with other drug-resistant genes.

[0057] 4. Sensitivity test of ddPCR detection method

[0058] According to the results of the specificity experiment, the original copy number of the template was obtained, and the original template was diluted to 10 -1 , 10 -2 , 10 -3 , 10 -4、 10 -5 The 5 concentration gradients were repeated for 3 groups in parallel. Each concentration was used as an amplification template. The sensitivity test of the ddPCR detection method was carried out using the drug-resistant gene AAC(6')-Ie as an example. The detection limit values ​​obtained were as follows: Figure 3 As shown, from left to right are 10 -1 -10 -5The minimum detection limits of the ddPCR detection method for AAC(6')-Ie, AAC(3)-IIa, ANT(6)-Ia, APH(6)-Id, APH(3")-Ib, tetA, tetB, tetD, tetO, and tetS were determined to be 0.06 copies / μL, 0.10 copies / μL, 0.24 copies / μL, 0.09 copies / μL, 0.23 copies / μL, 0.19 copies / μL,

[0059] 0.15 copies / μL, 0.31 copies / μL, 0.12 copies / μL, and 0.33 copies / μL, which shows that the ddPCR detection method has extremely high detection sensitivity and can achieve absolute quantification.

[0060] 5. Repeatability test of ddPCR detection method

[0061] According to the optimized droplet digital PCR detection conditions, 10 of the 10 drug resistance genes were used. -1 The concentration gradient nucleic acid was used as a template for ddPCR detection, and each group was repeated 3 times to evaluate the repeatability of the ddPCR detection method. In this repeatability test, the DNA of the bacterial species containing the drug-resistant gene shown by the second-generation sequencing results and the positive DNA verified by fluorescence was used as a template, and the established system was used for detection to obtain the droplet copy number.

[0062] Select 10 drug resistance genes -1 The repeatability test was carried out using nucleic acid of different concentrations as templates. According to the data shown in Table 6, the coefficients of variation of the 10 drug-resistant genes were distributed in a narrow range of 0.26%-0.81%. This result fully demonstrated that the ddPCR detection method established by the present invention has good repeatability.

[0063] Table 6 ddPCR repeatability test results

[0064]

[0065]

[0066] 6. Application of ddPCR detection method

[0067] 6.1 Sample processing

[0068] Because milk contains proteins and other substances that affect the extraction of bacterial DNA, before the formal droplet digital PCR test, the milk samples were artificially contaminated to conduct a preliminary experiment on the extraction of genomic DNA in milk. Three groups of control experiments were designed in the preliminary experiment, namely the boiling method, ammonium sulfate precipitation method and conventional extraction method to extract genomic DNA from artificially contaminated milk samples.

[0069] 60 portions of raw milk from 4 different batches of 5 brands were purchased from a supermarket. The 60 portions of raw milk were numbered 1-60, and genomic DNA was extracted from the raw milk.

[0070] 6.2. Detection of ARGs by qPCR and ddPCR

[0071] The extracted genomic DNA of 60 raw milk samples was used as qPCR and ddPCR templates, and the 60 raw milk samples were tested separately using the established qPCR and ddPCR detection methods for 10 drug-resistant genes.

[0072] 6.3 Results

[0073] In the pre-experimental genomic DNA extraction experiment of artificially contaminated milk samples, the boiling method, ammonium sulfate precipitation method and conventional extraction method can all achieve the extraction of genomic DNA, and there is no significant difference in extraction efficiency between the conventional extraction method and the other two methods, so the conventional extraction method can achieve the extraction of genomic DNA in raw milk. The test results are shown in Table 7.

[0074] Table 7 Detection of drug-resistant genes in 60 samples of raw milk

[0075]

[0076]

[0077] The results of the established ddPCR detection method for 10 drug-resistant genes in raw milk showed that among the 60 samples of commercially purchased raw milk, 1 sample was found to contain 1 copy / μL of the drug-resistant gene tetO, 1 sample was found to contain 10.2 copies / μL of the drug-resistant gene APH(6)-Id, and 1.8 copies / μL of the drug-resistant gene APH(3”)-Ib, 1 sample was found to contain 0.9 copies / μL of the drug-resistant gene AAC(6')-Ie, and 1 sample was found to contain 2.7 copies / μL of the drug-resistant gene tetA. However, the qPCR detection method only detected 1 sample of the drug-resistant gene APH(6)-Id with a Ct value of 34.7. The corresponding concentration of the Ct value calculated according to the standard curve was 7.481 cfu / mL.

[0078] The present invention discloses a droplet digital PCR detection method for drug-resistant genes in milk. Those skilled in the art can refer to the content of this article and appropriately improve the process parameters to achieve it. It should be particularly pointed out that all similar substitutions and modifications are obvious to those skilled in the art, and they are all considered to be included in the present invention. The products of the present invention have been described through preferred embodiments, and relevant personnel can obviously modify or appropriately change and combine the products described herein without departing from the content, spirit and scope of the present invention to implement and apply the technology of the present invention.

Claims

1. A droplet digital PCR method for detecting drug resistance genes in milk, characterized in that: The following steps are involved: (1) Prepare ddPCR reaction mixture, including: ddPCR Supermix, upstream primer, downstream primer, probe, DNA template and ddH2O; The sequence information of the upstream primer, downstream primer and probe is shown in the following table: (2) Droplet generation; (3) PCR amplification; The PCR reaction program was enzyme activation at 95°C for 8-10 min; denaturation at 94-98°C for 20-30 s for 35-45 cycles; annealing / extension at 50-60°C for 60-90 s for 35-45 cycles; enzyme inactivation at 98°C for 8-10 min; storage at 4°C; (4) Fluorescence signal reading and quantitative analysis results using QuantaSoft software.

2. The droplet digital PCR detection method for drug resistance genes in milk according to claim 1, characterized in that: The total volume of the ddPCR reaction mixture is 22 μL, including 11 μL of ddPCR Supermix, 1.8 μL of upstream primer, 1.8 μL of downstream primer, 0.5 μL of probe, 2.2 μL of DNA template, and 4.7 μL of ddH2O.

3. The droplet digital PCR detection method for drug resistance genes in milk according to claim 1, characterized in that: The drug-resistant genes in the milk are AAC(6')-Ie, AAC(3)-IIa, ANT(6)-Ia, APH(6)-Id, APH(3")-Ib, tetA, tetB, tetD, tetO and tetS.

4. The method for detecting drug-resistant genes in milk by droplet digital PCR according to claim 3, characterized in that: The minimum detection limits of the drug-resistant genes AAC(6')-Ie, AAC(3)-IIa, ANT(6)-Ia, APH(6)-Id, APH(3")-Ib, tetA, tetB, tetD, tetO and tetS were 0.06 copies / μL, 0.10 copies / μL, 0.24 copies / μL, 0.09 copies / μL, 0.23 copies / μL, 0.19 copies / μL, 0.15 copies / μL, 0.31 copies / μL, 0.12 copies / μL and 0.33 copies / μL, respectively.

5. The method for detecting drug-resistant genes in milk by droplet digital PCR according to claim 3, characterized in that: The coefficients of variation of the drug-resistant genes AAC(6')-Ie, AAC(3)-IIa, ANT(6)-Ia, APH(6)-Id, APH(3")-Ib, tetA, tetB, tetD, tetO and tetS are distributed in the range of 0.26%-0.81%.